MedTrace Logo

Surgical Sympathetic Blockade in Heart Failure

NCT01224899 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2010-10-20

No results posted yet for this study

Summary

The investigators sought to evaluate the feasibility and safety of surgical sympathetic blockade in systolic heart failure patients and secondary to assess its cardiovascular consequences.

Conditions

  • Systolic Heart Failure
  • Beta-blockers Intolerance
  • Beta-blockers Resistance

Interventions

PROCEDURE

Left cervico-thoracic sympathetic blockade

Left cervico-thoracic sympathetic blockade by videothoracoscopic clipping under general anesthesia and single-lumen orotracheal intubation in semi-sitting position.

Sponsors & Collaborators

  • University of Sao Paulo

    lead OTHER

Principal Investigators

  • Edimar A Bocchi, MD · Heart Institute (InCor) HC FMUSP

  • Paulo M Pego-Fernandes, MD · Heart Institute (InCor) HC FMUSP

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-12-31
Primary Completion
2009-11-30
Completion
2010-07-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01224899 on ClinicalTrials.gov